James M. Frincke
Nessuna posizione attualmente
Profilo
James M.
Frincke served as Vice President of Research & Development at Eli Lilly & Co., Hybritech, Inc., and Systemix, Inc. He was also President, CEO & Director at Harbor Diversified, Inc. and Chief Technical Officer at Premier Biomedical, Inc. Additionally, he served as VP of Therapeutics Research & Development at Prolinx, Inc. Frincke received his undergraduate and doctorate degrees from the University of California, Davis.
Precedenti posizioni note di James M. Frincke
| Società | Posizione | Fine |
|---|---|---|
| Prolinx, Inc. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Direttore Tecnico/Scientifico/R&S | 01/06/1995 |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/02/1991 |
| ELI LILLY AND COMPANY | Direttore Tecnico/Scientifico/R&S | 01/02/1991 |
| PREMIER BIOMEDICAL, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di James M. Frincke
| University of California, Davis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| HARBOR DIVERSIFIED, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| PREMIER BIOMEDICAL, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Prolinx, Inc. | |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
- Borsa valori
- Insiders
- James M. Frincke
